WGS — GeneDx Holdings Share News
0.000.00%
Last trade - 00:00- $2.09bn
- $2.06bn
- $427.54m
GeneDx Holdings Corp reports results for the quarter ended in March - Earnings Summary
Brief: Genedx Reports First Quarter 2023 Financial Results And Business Highlights
GeneDx Holdings Corp expected to post a loss of $2.80 a share - Earnings Preview
Brief: Genedx Announces Reverse Stock Split
U.S. RESEARCH ROUNDUP-Adobe, Five Below, Lennar
Brief: Genedx Reports Fourth Quarter And Full Year 2022 Financial Results And Business Highlights
GeneDx Holdings Corp reports results for the quarter ended in December - Earnings Summary
Brief: GeneDx Q4 Revenue Of $61.4 Million
GeneDx Holdings Corp expected to post a loss of 16 cents a share - Earnings Preview
Brief: Genedx Announces Closing Of Underwritten Public Offering And Concurrent Registered Direct Offering
Brief: GeneDx Holdings Announces Pricing Of $150 Mln Underwritten Public Offering Of Shares
Brief: Genedx Announces Proposed Underwritten Public Offering Of Class A Common Stock And Concurrent Registered Direct Offering
Brief: Sema4 Announces Name Change To Genedx And Provides Preliminary 2022 Financial Results And 2023 Guidance
Brief: Sema4 Holdings Gets Notice From Nasdaq That Co Did Not Satisfy Certain Continued Listing Requirement
U.S. RESEARCH ROUNDUP-Calithera Biosciences, Haynes International, Lumos Pharma
Brief: Sema4 Reports Q3 Financial Results And New Strategic Direction
Sema4 Holdings Corp reports results for the quarter ended in September - Earnings Summary
Sema4 Holdings Corp expected to post a loss of 21 cents a share - Earnings Preview
Brief: Sema4|Genedx Announces Results From Phase 1 Of Seqfirst Study